TGFB2

Chr 1AD

transforming growth factor beta 2

Also known as: CAEND2, G-TSF, LDS4, TGF-beta2

This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate a latency-associated peptide (LAP) and a mature peptide, and is found in either a latent form composed of a mature peptide homodimer, a LAP homodimer, and a latent TGF-beta binding protein, or in an active form consisting solely of the mature peptide homodimer. The mature peptide may also form heterodimers with other TGF-beta family members. Disruption of the TGF-beta/SMAD pathway has been implicated in a variety of human cancers. A chromosomal translocation that includes this gene is associated with Peters' anomaly, a congenital defect of the anterior chamber of the eye. Mutations in this gene may be associated with Loeys-Dietz syndrome. This gene encodes multiple isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Aug 2016]

OMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 0.152 OMIM phenotypes
Clinical SummaryTGFB2
🧬
Gene-Disease Validity (ClinGen)
familial thoracic aortic aneurysm and aortic dissection · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
131 unique Pathogenic / Likely Pathogenic· 409 VUS of 869 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?
0.15LOEUF
pLI 0.999
Z-score 4.16
OE 0.00 (0.000.15)
Highly constrained

Among the most LoF-intolerant genes (~top 3%)

Missense Constraint?
2.13Z-score
OE missense 0.62 (0.540.71)
153 obs / 247.3 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.00 (0.000.15)
00.351.4
Missense OE?0.62 (0.540.71)
00.61.4
Synonymous OE?1.02
01.21.6
LoF obs/exp: 0 / 20.1Missense obs/exp: 153 / 247.3Syn Z: -0.15
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveTGFB2-related Loeys-Dietz syndromeLOFAD

This gene — mechanism propensity

DN
0.3495th %ile
GOF
0.2497th %ile
LOF
0.66top 25%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · 1 literature citation · 76% of P/LP variants are LoF · LOEUF 0.15

Literature Evidence

LOFLoss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 22772368

ClinVar Variant Classifications

869 submitted variants in ClinVar

Classification Summary

Pathogenic76
Likely Pathogenic55
VUS409
Likely Benign257
Benign37
Conflicting27
76
Pathogenic
55
Likely Pathogenic
409
VUS
257
Likely Benign
37
Benign
27
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
60
3
13
0
76
Likely Pathogenic
39
10
6
0
55
VUS
11
322
70
6
409
Likely Benign
0
7
86
164
257
Benign
0
0
37
0
37
Conflicting
27
Total110342212170861

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

35 pathogenic / likely-pathogenic (of 44) ClinVar copy-number / structural variants overlap TGFB2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TGFB2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →